Cord tissue is the tissue found in the umbilical cord. Scientists have found that your baby’s umbilical cord is an exceptional source of valuable stem cells.
Umbilical cord tissue stem cells are vastly different from cord blood stem cells, but equally important. They can potentially be used to treat different types of diseases and conditions within the body.
Banking cord tissue stem cells is a wise choice for your family as they may be used for stem cell therapies and future disease treatment.
Cord tissue stem cells are found in the Wharton’s Jelly and perivascular regions of the umbilical cord.
To date, the vast amount of research on cord tissue stem cells has been focussed on the Mesenchymal Stem Cells or MSCs found in cord tissue.
MSCs are showing great potential in the fields of regenerative medicine, tissue engineering and gene therapy. They are a different kind of stem cell from the hematopoietic stem cells (HCSs) found in cord blood, and they can differentiate into a variety of cell types, including bone, cartilage, muscle, nerve and others.
Because of their versatility, MCSs derived from cord tissue may have the potential to treat even more than the 80 diseases and conditions that are already FDA-approved for treatment with cord blood stem cells.
Cord tissue banking is the process of safely collecting, processing, and storing your baby’s umbilical cord tissue for potential use in the treatment of future diseases or conditions. The umbilical cord is rich in stem cells that may be extremely valuable in future stem cell therapies. After your baby’s cord tissue is processed, those precious stem cells are stored in a private cord blood bank that is accessible to your family at any point in the future when they are needed.
Mesenchymal stem cells from cord tissue represent the most advanced, cutting-edge discoveries in regenerative medicine today.
The use of cord tissue stem cells has the enormous potential to make regenerative medicine a life-saving reality. This is something that conventional medicine and pharmaceutical therapy have not been able to do effectively.
Also, the ability of cord tissue stem cells to suppress the body’s immune response has prompted doctors to transplant them in unison with cord blood stem cells to significantly reduce the effects of transplant rejection or Graft Versus Host Disease (GVHD).
By using cord tissue stem cells along with cord blood stem cells, researchers have also reported quicker cell engraftment and improved transplant outcomes.
The difference between umbilical cord blood and cord tissue lies in the different types of stem cells that are found in each, and the role each type of cell plays in regeneration or self-healing.
Cord blood stem cells can differentiate into any blood component and are used to treat various cancers, metabolic disorders, and blood and immune system diseases. Cord blood stem cells have shown to be highly effective in the treatment of over 80 diseases and conditions that are already FDA-approved.
The mesenchymal stem cells derived from cord tissue can differentiate into many kinds of cells including skin, bone, fat, muscle, cartilage and organ cells. MSCs’ ability to fulfill many regenerative roles within the body poses significant promise in the future treatment of many types of diseases.
With over 300 MSC clinical trials and numerous research studies in process, scientists predict there will be an explosion of new therapies using cord tissue stem cells, as they represent the most advanced, cutting-edge discoveries in regenerative medicine today.
It is anticipated that new therapies will be universally adopted, and include standard, routine treatments for autism, type 1 diabetes, Alzheimer’s, spinal cord injury, traumatic brain injury, Parkinson’s disease, rheumatoid arthritis, multiple sclerosis, stroke, heart failure, liver damage and many more.
Some of the Clinical Trials Using MSCs:
Private banking of both cord blood and cord tissue will provide your family with the most complete scope of future treatment options.